MaxCyte, Inc. (MXCT) Operating margin 2019–2025
MaxCyte, Inc. (MXCT) operating margin by fiscal year — reported operating income divided by reported revenue.
-247.6%FY2025 · since FY2019: -93.7% → -247.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -247.6% | -17.2 pp |
| FY2024 | -230.5% | +17.3 pp |
| FY2023 | -247.7% | -152.5 pp |
| FY2022 | -95.2% | -10.9 pp |
| FY2021 | -84.3% | -12.8 pp |
| FY2020 | -71.6% | +22.1 pp |
| FY2019 | -93.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice